Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Ottawa
$105,000.00
Molecular clues to the atheroprotective effects of Estrogens: Novel extracellular signaling role of Heat Shock Protein 27
EF 2008-09
Résumé
Compared to men, women are protected against heart disease until menopause. These observations imply that the hormone estrogen, or related factors, which are normally present before menopause and disappear thereafter, may be protective against the development of blood vessel disease. Trials involving the use of hormone replacement therapy (HRT) after menopause have been unsuccessful; therefore more information is needed about how estrogen may protect blood vessels.
Estrogens interact with cells by binding to receptors that translate their signal into the cell. Dr. O'Brien's lab has discovered an interesting protein called Heat Shock Protein 27 (HSP27) that increases in abundance when cells are treated with estrogen. HSP27 physically interacts with estrogen receptors to influence how they respond to estrogen. His laboratory also discovered that when human coronary arteries become hardened (atherosclerosis), they make less than the usual amount of HSP27. Conversely, they found that mice prone to developing atherosclerosis have a 35% reduction in disease when their cells are artificially engineered to make increased HSP27. Therefore, understanding why HSP27 is important in the development of atherosclerosis is a critical question that I will pursue through my research.
My goal is to unravel the mystery of the protective effect of HSP27 by looking at what genetic information is different in mice that develop hardening of the arteries compared to mice that over-express HSP27. Using "gene chips" (microarrays) we will compare the gene expression patterns in the arteries and immune cells of these two mice strains. Hence, our results will then pinpoint a specific subset of genes that are altered in the presence of HSP27.
In summary, this study will provide new genetic information on how HSP27, is protective against the development of atherosclerosis. As such, this study may have direct relevance with respect to the use and safety of HRT in post-menopausal women.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184520
Name
Seibert Tara A
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular clues to the atheroprotective effects of Estrogens: Novel extracellular signaling role of Heat Shock Protein 27
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Animal Models Of Atherosclerosis; Array Analysis Softwares; Gene Expression Profiling; In Vitro Cell Assays; Inflammatory Processes; Molecular Imaging; Novel Mechanisms Of Preventing Plaque Development; Pathway Modeling/Systems Biology; Prevention Of Athersclerosis And Coronary Artery Disease; Real Time Pcr (Taqman Probes)
Abstract
Compared to men, women are protected against heart disease until menopause. These observations imply that the hormone estrogen, or related factors, which are normally present before menopause and disappear thereafter, may be protective against the development of blood vessel disease. Trials involving the use of hormone replacement therapy (HRT) after menopause have been unsuccessful; therefore more information is needed about how estrogen may protect blood vessels.
Estrogens interact with cells by binding to receptors that translate their signal into the cell. Dr. O'Brien's lab has discovered an interesting protein called Heat Shock Protein 27 (HSP27) that increases in abundance when cells are treated with estrogen. HSP27 physically interacts with estrogen receptors to influence how they respond to estrogen. His laboratory also discovered that when human coronary arteries become hardened (atherosclerosis), they make less than the usual amount of HSP27. Conversely, they found that mice prone to developing atherosclerosis have a 35% reduction in disease when their cells are artificially engineered to make increased HSP27. Therefore, understanding why HSP27 is important in the development of atherosclerosis is a critical question that I will pursue through my research.
My goal is to unravel the mystery of the protective effect of HSP27 by looking at what genetic information is different in mice that develop hardening of the arteries compared to mice that over-express HSP27. Using "gene chips" (microarrays) we will compare the gene expression patterns in the arteries and immune cells of these two mice strains. Hence, our results will then pinpoint a specific subset of genes that are altered in the presence of HSP27.
In summary, this study will provide new genetic information on how HSP27, is protective against the development of atherosclerosis. As such, this study may have direct relevance with respect to the use and safety of HRT in post-menopausal women.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Seibert, Tara A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~